Overview

Minimal Effective Concentration (EC90) of Ropivacaine

Status:
Completed
Trial end date:
2020-05-04
Target enrollment:
Participant gender:
Summary
Prospective up and down sequential evaluation of the minimal effective concentration of perineural ropivacaine for 90% success in axillary brachial plexus block with the injection of intravenous dexamethasone or saline placebo during regional anesthesia performance
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Ropivacaine